The pharmacotherapy of Tourette syndrome.
D001590:Benztropine / Q000627:therapeutic use; D004409:Dyskinesia, Drug-Induced / Q000188:drug therapy / Q000209:etiology; D006220:Haloperidol / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D010302:Parkinson Disease, Secondary / Q000139:chemically induced / Q000188:drug therapy; D005879:Tourette Syndrome / Q000188:drug therapy*
D001590:Benztropine; D006220:Haloperidol